Luis Villalobos-Gallegos

Prof. Luis Villalobos-Gallegos

School of Medicine and Psychology, Universidad Autónoma de Baja California, Tijuana, Baja California, Mexico
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2015 in Salud mental
Verified
Journal Article
Closed access
Luis Villalobos-GallegosLuis Villalobos-Gallegos
Luis Villalobos-Gallegos
U(Unidad de Ensayos Clínicos En Adicciones Y Salud Mental. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz (Inprfm)
Unidad de Ensayos Clínicos En Adicciones Y Salud Mental. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz (Inprfm)
APAlejandro Pérez
Alejandro Pérez
RMRebeca Mendoza
Rebeca Mendoza
JGJavier Graue
Javier Graue
C9Centro Histórico. Zip Code: 76000. Querétaro Comisión Estatal Contra Las Adicciones de Querétaro. Independencia 97
Centro Histórico. Zip Code: 76000. Querétaro Comisión Estatal Contra Las Adicciones de Querétaro. Independencia 97
Background. The use of reliable and valid self-report questionnaires to identify drug use disorders (DUD) is a strategy that has shown usefulness for screening. One of the instruments more used for detection is the Drug Abuse Screening Test (DAST). The psychometric properties in the 20- and 10-item versions have been evaluated in other countries but in Mexico the psychometric and diagnostic properties of both versions are yet to be evaluated. Objective. The purpose of this study was to evaluate the psychometric and diagnostic properties of DAST-20 and -10. Method. The sample included 565 participants receiving care in addiction residential centers. The DAST-20 was used as a measure to screen for DUD, and the Mini International Neuropsychiatric Interview 5.0 was used as “gold standard” for the DUD diagnosis. Cronbach’s α and CFA were estimated in order to evaluate the psychometric properties. The Receiver Operator Characteristic (ROC) analysis was used to examine the diagnostic properties of each version. Results. Both versions obtained a Cronbach’s α ≥ .80, an optimal goodness of fit for the one factor model and Areas Under the Curve ≥ .90 (95% CI 87-93) for both versions. Discussion and conclusion. DAST-20 and -10 versions are reliable and valid tools for DUD assessment and screening.

5 August 2016 in Journal of Dual Diagnosis
Verified
Journal Article
Closed access
RMRodrigo Marín-Navarrete
Rodrigo Marín-Navarrete
MMMaría Elena Medina-Mora
María Elena Medina-Mora
VHViviana E. Horigian
Viviana E. Horigian
ISIhsan M. Salloum
Ihsan M. Salloum
Luis Villalobos-GallegosLuis Villalobos-Gallegos
Luis Villalobos-Gallegos
JFJosé Fernández-Mondragón
José Fernández-Mondragón
Objective: In Mexico, specialized treatment services for people with co-occurring disorders are limited within public health services, while private options are deemed too costly. More than 2,000 community-based residential care facilities have risen as an alternative and are the main source of treatment for individuals with substance use disorders; however, suboptimal practices within such facilities are common. Information on the clinical characteristics of patients receiving care in these facilities is scarce and capacity to provide high-quality care for co-occurring disorders is unknown. The aims of this study were to examine the prevalence of co-occurring disorders in patients receiving treatment for substance use in these community-based residential centers and to assess whether the presence of co-occurring disorders is associated with higher severity of substance use, psychiatric symptomatology, and other health risks. Methods: This study was conducted with 601 patients receiving treatment for substance use disorders at 30 facilities located in five Mexican states, recruited in 2013 and 2014. Patients were assessed with self-report measures on substance use, service utilization, suicidality, HIV risk behaviors, psychiatric symptomatology, and psychiatric disorder diagnostic criteria. Results: The prevalence of any co-occurring disorder in this sample was 62.6%. Antisocial personality disorder was the most prevalent (43.8%), followed by major depressive disorder (30.9%). The presence of a co-occurring disorder was associated with higher severity of psychiatric symptoms (aB = .496, SE = .050, p < .05); more days of substance use (aB = .219, SE = .019, p < .05); current suicidal ideation (aOR = 5.07, 95% CI [2.58, 11.17]; p < .05), plans (aOR = 5.17 95% CI [2.44, 12.73]; p < .05), and attempts (aOR = 6.43 95% CI [1.83, 40.78]; p < .05); more sexual risk behaviors; and more contact with professional services (aOR = 1.77, 95% CI [1.26, 2.49], p < .05). Conclusions: Co-occurring disorders are highly prevalent in community-based residential centers in Mexico and are associated with significantly increased probability of other health risks. This highlights the need to develop care standards for this population and the importance of clinical research in these settings.

1 January 2017 in Journal of Addictions Nursing
Verified
Journal Article
Closed access
PDF file
AMAna Moreno-Coutiño
Ana Moreno-Coutiño
Luis Villalobos-GallegosLuis Villalobos-Gallegos
Luis Villalobos-Gallegos
The Fagerström Test for Nicotine Dependence (FTND) is a widely used six-item questionnaire, often used as a measure of physical dependence on nicotine, although evidence of its validity in Spanish-language studies is scarce. The aim of this study was to assess the psychometric properties of FTND in Spanish speakers. We recruited 136 regular adult smokers to answer the FTND. We assessed the internal consistency of the FTND with a Cronbach’s alpha and convergent and divergent validity with the Pearson product–moment coefficient between variables of external criteria, both measure and nonmeasure related; the FTND items, and the total score. We performed a binary logistic regression model to determine predictive validity of the questionnaire, using the FTND total scores as an independent variable and cessation as the outcome. We performed a confirmatory factor analysis to assess the robustness of a single-factor model. The internal consistency had a lower coefficient than current standards. The FTND was unable to predict cessation at any assessed time point. The FTND total score showed significant correlation with exhaled carbon monoxide, urinary cotinine, and self-report of cigarettes smoked per day. However, Items 5 (smoke in the first hours) and 6 (smoke if ill) failed to obtain a significant correlation with biological biomarkers. Although the FTND showed an adequate construct validity, the results suggest that its convergent and predictive validity is limited; therefore, it might not be suitable for the Mexican population. More studies in other populations are needed to establish the generalizability of these findings.

1 September 2018 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
RMRodrigo Marín-Navarrete
Rodrigo Marín-Navarrete
ATAldebarán Toledo-Fernández
Aldebarán Toledo-Fernández
Luis Villalobos-GallegosLuis Villalobos-Gallegos
Luis Villalobos-Gallegos
APAlejandro Pérez-López
Alejandro Pérez-López
MMMaría Elena Medina-Mora
María Elena Medina-Mora

29 May 2018 in Archives of Sexual Behavior
Verified
Journal Article
Closed access
PDF file
Luis Villalobos-GallegosLuis Villalobos-Gallegos
Luis Villalobos-Gallegos
MMMaría Elena Medina-Mora
María Elena Medina-Mora
CBCorina Benjet
Corina Benjet
SRSilvia Ruiz-Velasco
Silvia Ruiz-Velasco
CMCarlos Magis-Rodriguez
Carlos Magis-Rodriguez
RMRodrigo Marín-Navarrete
Rodrigo Marín-Navarrete

11 July 2014 in Substance Use & Misuse
Verified
Journal Article
Closed access
RMRodrigo Marín-Navarrete
Rodrigo Marín-Navarrete
LTLiliana Templos-Nuñez
Liliana Templos-Nuñez
AEAngélica Eliosa-Hernández
Angélica Eliosa-Hernández
Luis Villalobos-GallegosLuis Villalobos-Gallegos
Luis Villalobos-Gallegos
JFJosé Fernández-Mondragón
José Fernández-Mondragón
VHViviana E. Horigian
Viviana E. Horigian
Baseline patients' characteristics are critical for treatment planning, as these can be moderators of treatment effects. In Mexico, information on treatment seekers with substance use disorders is scarce and limited to demographic characteristics. This paper presents and analyses demographic characteristics, substance use related problems, clinical features, and addiction severity in a sample of treatment seekers from the first multi-site randomized clinical trial implemented in the Mexican Clinical Trials Network on Addiction and Mental Health. A total of 120 participants were assessed prior randomization. Chi square or F-tests were used to compare sites across variables. Spearman correlation was used to associate negative consequences of substance use and motivation to change. The majority of participants were men, and the most prevalent substances reported were alcohol, marijuana, and cocaine. Participants were predominantly on the contemplation or action stage of change, and this was correlated with the perception of the negative consequences associated with substance use. Participants reported a high prevalence of substance use related problems. Substance use related problems, clinical features, and addiction severity reported by treatment seekers are important characteristics to take into account when planning treatment as they facilitate tailoring treatment to meet patients' needs.